TY - JOUR
T1 - Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae
AU - Vizarraga, David
AU - Kawamoto, Akihiro
AU - Matsumoto, U.
AU - Illanes, Ramiro
AU - Pérez-Luque, Rosa
AU - Martín, Jesús
AU - Mazzolini, Rocco
AU - Bierge, Paula
AU - Quijada Pich, Oscar
AU - Espasa, Mateu
AU - Sanfeliu, Isabel
AU - Esperalba, Juliana
AU - Fernández-Huerta, Miguel
AU - Scheffer, Margot P.
AU - Pinyol, Jaume
AU - Frangakis, Achilleas S.
AU - Lluch Senar, Maria
AU - Mori, Shigetarou
AU - Shibayama, Keigo
AU - Kenri, Tsuyoshi
AU - Kato, Takayuki
AU - Namba, Keiichi
AU - Fita, Ignacio
AU - Miyata, Makoto
AU - Aparicio Alarcón, David
PY - 2020
Y1 - 2020
N2 - Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.
AB - Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.
U2 - 10.1038/s41467-020-18777-y
DO - 10.1038/s41467-020-18777-y
M3 - Article
C2 - 33057023
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
ER -